These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 19591849

  • 1. Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways.
    Lebel M, Patenaude C, Allyson J, Massicotte G, Cyr M.
    Neuropharmacology; 2009 Sep; 57(4):392-402. PubMed ID: 19591849
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M, Baranowska-Bosiacka I, Moczydłowska J, Tarnowski M, Pilutin A, Gutowska I, Strużyńska L, Chlubek D, Adamczyk A.
    Toxicology; 2016 Mar 10; 347-349():17-28. PubMed ID: 27012722
    [Abstract] [Full Text] [Related]

  • 4. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI, Ansar S, Li G, Bean J, Michaelis ML, Dobrowsky RT.
    J Mol Neurosci; 2007 Mar 10; 31(1):23-35. PubMed ID: 17416967
    [Abstract] [Full Text] [Related]

  • 5. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH, Ban T, Liu CD, Chen QX, Wang X, Yan ML, Hu XL, Su XL, Bao YN, Sun LL, Zhao LJ, Pei SC, Jiang XM, Zong DK, Ai J.
    J Neurochem; 2015 Sep 10; 134(6):1139-51. PubMed ID: 26118667
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage.
    Sui HJ, Zhang LL, Liu Z, Jin Y.
    Acta Pharmacol Sin; 2015 May 10; 36(5):553-64. PubMed ID: 25891085
    [Abstract] [Full Text] [Related]

  • 7. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
    Crespo-Biel N, Canudas AM, Camins A, Pallàs M.
    Neurochem Int; 2007 Jan 10; 50(2):435-42. PubMed ID: 17116346
    [Abstract] [Full Text] [Related]

  • 8. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE.
    J Neurosci; 2008 Mar 05; 28(10):2624-32. PubMed ID: 18322105
    [Abstract] [Full Text] [Related]

  • 9. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP, Xie JW, Wang CY, Wang T, Wang X, Wang SL, Teng WP, Wang ZY.
    Brain Res Bull; 2011 May 30; 85(3-4):194-200. PubMed ID: 21435383
    [Abstract] [Full Text] [Related]

  • 10. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
    Annamalai B, Won JS, Choi S, Singh I, Singh AK.
    Biochem Biophys Res Commun; 2015 Feb 27; 458(1):214-9. PubMed ID: 25640839
    [Abstract] [Full Text] [Related]

  • 11. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
    Han P, Dou F, Li F, Zhang X, Zhang YW, Zheng H, Lipton SA, Xu H, Liao FF.
    J Neurosci; 2005 Dec 14; 25(50):11542-52. PubMed ID: 16354912
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
    Li T, Hawkes C, Qureshi HY, Kar S, Paudel HK.
    Biochemistry; 2006 Mar 14; 45(10):3134-45. PubMed ID: 16519508
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
    Cho DH, Lee EJ, Kwon KJ, Shin CY, Song KH, Park JH, Jo I, Han SH.
    J Neurochem; 2013 Sep 14; 126(5):685-95. PubMed ID: 23581463
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.